X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
humans (38) 38
female (26) 26
male (24) 24
hepacivirus - genetics (20) 20
genotype (19) 19
middle aged (19) 19
virology (18) 18
adult (17) 17
settore med/07 - microbiologia e microbiologia clinica (17) 17
infectious diseases (16) 16
antiviral agents - therapeutic use (15) 15
hepatitis c virus (14) 14
hepatitis c, chronic - drug therapy (14) 14
hepacivirus - drug effects (12) 12
mutation (12) 12
treatment failure (11) 11
aged (10) 10
drug therapy, combination (10) 10
hepatitis c (10) 10
molecular sequence data (10) 10
antiviral agents (9) 9
hcv (9) 9
infection (9) 9
phylogeny (9) 9
rna (9) 9
viral nonstructural proteins - genetics (9) 9
drug resistance, viral - genetics (8) 8
gastroenterology & hepatology (8) 8
health aspects (8) 8
microbiology (8) 8
sequence analysis, dna (8) 8
analysis (7) 7
cirrhosis (7) 7
drug resistance (7) 7
drug-resistance (7) 7
gastroenterology and hepatology (7) 7
genetic variation (7) 7
italy (7) 7
patients (7) 7
pharmacology & pharmacy (7) 7
antiviral agents - pharmacology (6) 6
direct-acting antivirals (6) 6
drug resistance, viral (6) 6
hepatitis c - drug therapy (6) 6
hepatitis c, chronic - virology (6) 6
interferon (6) 6
mutation, missense (6) 6
prevalence (6) 6
recurrence (6) 6
therapy (6) 6
treatment outcome (6) 6
antiviral agents - administration & dosage (5) 5
care and treatment (5) 5
genetic aspects (5) 5
genotyping techniques (5) 5
hepatitis (5) 5
hepatitis b surface antigens - genetics (5) 5
hepatitis-c virus (5) 5
hiv infections - virology (5) 5
hiv-1 - genetics (5) 5
medicine (5) 5
protease inhibitors (5) 5
protease inhibitors - therapeutic use (5) 5
resistance (5) 5
ribavirin (5) 5
ribavirin - therapeutic use (5) 5
sofosbuvir (5) 5
telaprevir (5) 5
variants (5) 5
virus diseases (5) 5
amino acid sequence (4) 4
amino acid substitution (4) 4
base sequence (4) 4
biological response modifiers (4) 4
dna, viral - genetics (4) 4
genotype & phenotype (4) 4
genotype 1 (4) 4
hepacivirus - classification (4) 4
hepacivirus - isolation & purification (4) 4
hepatitis b (4) 4
hepatitis b virus - genetics (4) 4
hepatitis c - virology (4) 4
hepatitis-b-virus (4) 4
hiv (4) 4
hiv infections - drug therapy (4) 4
human immunodeficiency virus--hiv (4) 4
immunology (4) 4
liver (4) 4
medical colleges (4) 4
papillomavirus infections - virology (4) 4
polymorphism, genetic (4) 4
proteases (4) 4
research article (4) 4
rna, viral - genetics (4) 4
sustained virologic response (4) 4
viral load (4) 4
young adult (4) 4
amino acids (3) 3
anti-hiv agents - pharmacology (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Bertoli, Ada and Sorbo, Maria Chiara and Aragri, Marianna and Lenci, Ilaria and Teti, Elisabetta and Polilli, Ennio and Di Maio, Velia Chiara and Gianserra, Laura and Biliotti, Elisa and Masetti, Chiara and Magni, Carlo F and Babudieri, Sergio and Nicolini, Laura A and Milana, Martina and Cacciatore, Pierluigi and Sarmati, Loredana and Pellicelli, Adriano and Paolucci, Stefania and Craxì, Antonio and Morisco, Filomena and Palitti, Valeria Pace and Siciliano, Massimo and Coppola, Nicola and Iapadre, Nerio and Puoti, Massimo and Rizzardini, Giuliano and Taliani, Gloria and Pasquazzi, Caterina and Andreoni, Massimo and Parruti, Giustino and Angelico, Mario and Perno, Carlo Federico and Cento, Valeria and Ceccherini-Silberstein, Francesca and Andreone, Pietro and Baldanti, Fausto and Barbarini, Giorgio and Boccaccio, Vincenzo and Boglione, Lucio and Bolis, Matteo and Bonora, Stefano and Borghi, Vanni and Brancaccio, Giuseppina and Bruno, Savino and Bruzzone, Bianca and Calvaruso, Vincenza and Caporaso, Nicola and Ciaccio, Antonio and Ciancio, Alessia and Colombatto, Piero and Cozzolongo, Raffaele and D'Ambrosio, Cecilia and D'Ettorre, Gabriella and De Leonardis, Francesco and De Luca, Andrea and Di Biagio, Antonio and Di Perri, Giovanni and Francioso, Simona and Gaeta, Giovanni Battista and Gasbarrini, Antonio and Ghisetti, Valeria and Giorgini, Alessia and Grieco, Antonio and Gubertini, Guido and Gulminetti, Roberto and Lambiase, Lara and Landonio, Simona and Lichtner, Miriam and Maida, Ivana and Marenco, Simona and Marinaro, Letizia and Maserati, Renato and Melis, Michela and Menzaghi, Barbara and Meregalli, Elisa and Micheli, Valeria and Niero, Fosca and Paoloni, Maurizio and Pieri, Alessandro and Rendina, Maria and Romagnoli, Dante and Rossetti, Barbara and Ruggiero, Tina and Sangiovanni, Vincenzo and Starace, Mario and Sticchi, Laura and Tarquini, Pierluigi and Toniutto, Pierluigi and Vullo, Vincenzo and Zazzi, Maurizio and Hcv Virology Italian Resistance Ne and HCV Virology Italian Resistance Network (VIRONET-C)
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 8988 - 11
Natural resistance-associated substitutions (RASs) are reported with highly variable prevalence across different HCV genotypes (GTs). Frequency of natural RASs... 
GLECAPREVIR | TREATMENT-NAIVE | REAL-LIFE | PIBRENTASVIR | CIRRHOSIS | MULTIDISCIPLINARY SCIENCES | SIMEPREVIR PLUS SOFOSBUVIR | RESPONSE RATES | DIRECT-ACTING ANTIVIRALS | 1 INFECTION | OPEN-LABEL | Hepatitis C | Disease resistance | Genotypes
Journal Article
by Di Maio, Velia C and Cento, Valeria and Lenci, Ilaria and Aragri, Marianna and Rossi, Piera and Barbaliscia, Silvia and Melis, Michela and Verucchi, Gabriella and Magni, Carlo F and Teti, Elisabetta and Bertoli, Ada and Antonucci, FrancescoPaolo and Bellocchi, Maria C and Micheli, Valeria and Masetti, Chiara and Landonio, Simona and Francioso, Simona and Santopaolo, Francesco and Pellicelli, Adriano M and Calvaruso, Vincenza and Gianserra, Laura and Siciliano, Massimo and Romagnoli, Dante and Cozzolongo, Raffaele and Grieco, Antonio and Vecchiet, Jacopo and Morisco, Filomena and Merli, Manuela and Brancaccio, Giuseppina and Di Biagio, Antonio and Loggi, Elisabetta and Mastroianni, Claudio M and Pace Palitti, Valeria and Tarquini, Pierluigi and Puoti, Massimo and Taliani, Gloria and Sarmati, Loredana and Picciotto, Antonino and Vullo, Vincenzo and Caporaso, Nicola and Paoloni, Maurizio and Pasquazzi, Caterina and Rizzardini, Giuliano and Parruti, Giustino and Craxì, Antonio and Babudieri, Sergio and Andreoni, Massimo and Angelico, Mario and Perno, Carlo F and Ceccherini‐Silberstein, Francesca and Mariani, R and Iapadre, N and Grimaldi, A and Cozzolongo, R and Andreone, P and Verucchi, G and Menzaghi, B and Quirino, T and Pisani, V and Torti, C and Vecchiet, J and Bruzzone, B and De Maria, A and Marenco, S and Nicolini, L.A and Viscoli, C and Casinelli, K and Delle Monache, M and Lichtner, M and Aghemo, A and Boccaccio, V and Bruno, S and Cerrone, M and Colombo, M and D'Arminio Monforte, A and Danieli, E and Donato, F and Gubertini, G and Lleo, A and Magni, C.F and Mancon, A and Monico, S and Niero, F and Russo, M.L and Gnocchi, M and Orro, A and Milanesi, L and Baldelli, E and Bertolotti, M and Borghi, V and Mussini, C and Brancaccio, G and Gaeta, G.B and Lembo, V and Sangiovanni, V and Di Marco, V and Mazzola, A and Petta, S and D'Amico, E and Cacciatore, P and ... and HCV Italian Resistance Network Stu and HCV Italian Resistance Network Study Group and the HCV Italian Resistance Network Study Group
Liver International, ISSN 1478-3223, 04/2017, Volume 37, Issue 4, pp. 514 - 528
Journal Article
by Di Maio, Velia Chiara and Cento, Valeria and Aragri, Marianna and Paolucci, Stefania and Pollicino, Teresa and Coppola, Nicola and Bruzzone, Bianca and Ghisetti, Valeria and Zazzi, Maurizio and Brunetto, Maurizia and Bertoli, Ada and Barbaliscia, Silvia and Galli, Silvia and Gennari, William and Baldanti, Fausto and Raimondo, Giovanni and Perno, Carlo Federico and Ceccherini-Silberstein, Francesca and Andreone, Pietro and Andreoni, Massimo and Angelico, Mario and Babudieri, Sergio and Barbarini, Giorgio and Boccaccio, Vincenzo and Boglione, Lucio and Bolis, Matteo and Bonora, Stefano and Borghi, Vanni and Brancaccio, Giuseppina and Bruno, Savino and Cacciatore, Pierluigi and Calvaruso, Vincenza and Caporaso, Nicola and Ciaccio, Antonio and Ciancio, Alessia and Colombatto, Piero and Cozzolongo, Raffaele and Craxì, Antonio and D'Ambrosio, Cecilia and D'Ettorre, Gabriella and De Luca, Andrea and Di Biagio, Antonio and Di Perri, Giovanni and Francioso, Simona and Gaeta, Giovanni Battista and Giorgini, Alessia and Grieco, Antonio and Gubertini, Guido and Gulminetti, Roberto and Lambiase, Lara and Lenci, Ilaria and Lichtner, Miriam and Maida, Ivana and Marenco, Simona and Marinaro, Letizia and Maserati, Renato and Masetti, Chiara and Melis, Michela and Meregalli, Elisa and Micheli, Valeria and Morisco, Filomena and Niero, Fosca and Nicolini, Laura Ambra and Palitti, Valeria Pace and Paoloni, Maurizio and Parruti, Giustino and Pasquazzi, Caterina and Pellicelli, Adriano and Polilli, Ennio and Ponti, Maria Laura and Puoti, Massimo and Rendina, Maria and Rizzardini, Giuliano and Rossetti, Barbara and Ruggiero, Tina and Sangiovanni, Vincenzo and Starace, Mario and Sticchi, Laura and Tarquini, Pierluigi and Toniutto, Pierluigi and Vullo, Vincenzo and HCV Virology Italian Resistance Network (VIRONET-C)
Journal of Hepatology, ISSN 0168-8278, 03/2018, Volume 68, Issue 3, pp. 597 - 600
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 2/2012, Volume 205, Issue 4, pp. 557 - 567
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, p. e0177352
Background Intracellular HCV-RNA reduction is a proposed mechanism of action of direct-acting antivirals (DAAs), alternative to hepatocytes elimination by... 
PROTEASE INHIBITOR | INTERFERON-ALPHA | TELAPREVIR | HEPATITIS-C VIRUS | MULTIDISCIPLINARY SCIENCES | TREATMENT-EXPERIENCED PATIENTS | TRIPLE THERAPY | ALANINE AMINOTRANSFERASE | INFECTED-CELLS | RIBAVIRIN | DYNAMICS IN-VIVO | Hepatitis C - drug therapy | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Alanine Transaminase - blood | Simeprevir - administration & dosage | Ribavirin - administration & dosage | Female | Drug Therapy, Combination | Antiviral Agents - pharmacology | Sofosbuvir - pharmacology | Administration, Oral | Interferons - pharmacology | Treatment Outcome | Antiviral Agents - administration & dosage | Simeprevir - pharmacology | Sofosbuvir - administration & dosage | Aged | Oligopeptides - administration & dosage | Alanine Transaminase - metabolism | Kinetics | Oligopeptides - pharmacology | Viral Nonstructural Proteins - antagonists & inhibitors | Ribavirin - pharmacology | Care and treatment | RNA | Dynamics | Interferon | Alanine aminotransferase | Research | Drug therapy | Hepatitis C | Liver cirrhosis | Syngeneic grafts | Liver | Proteinase | Antiinfectives and antibacterials | Tropical diseases | Hepatitis | Genotype & phenotype | Surgery | Damage | Liver diseases | Mortality | Cirrhosis | Chemotherapy | Hospitals | Infectious diseases | Inhibitors | Hepatocytes | Adults | Clinical medicine | Liver transplantation | Drugs | Health sciences | Microbiology | Medical services | Population studies | Viruses | Transplantation | Infections | Immunosuppressive agents | Biomedical materials | Reduction | Hepatology | Gastroenterology | Mathematical models | Clinical microbiology | Enzyme-linked immunosorbent assay | CpG islands | Antiviral agents | Alanine | Receiving | Health | Markers | Antimicrobial agents | Pharmacology | Ribonucleic acid--RNA | Medicine | Cell death | Decay | Ribonucleic acid
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2017, Volume 72, Issue 12, pp. 3420 - 3424
Background: Pretreatment evaluation of HCV-infected patients is a complex interplay between multiple clinical and viral parameters, leading to a tailored... 
INFECTIOUS DISEASES | NS5A | CIRRHOSIS | RESISTANCE-ASSOCIATED SUBSTITUTIONS | SIMEPREVIR PLUS SOFOSBUVIR | GENOTYPE 1 INFECTION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PREVALENCE | PHASE-3 | ANTIVIRAL DRUGS
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e53603
Journal Article
Journal of global antimicrobial resistance, 08/2019
In HIV-positive population, a paradigm shift from three-drug regimens to dolutegravir-based two-drug regimens as both initial and switch treatment approach is... 
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2012, Volume 7, Issue 7, p. e39652
Journal Article
Liver International, ISSN 1478-3223, 05/2017, Volume 37, Issue 5, pp. 653 - 661
Journal Article